Published in Cancer Weekly, March 20th, 2012
"So, the objective of the present investigation was to characterize the antiproliferative activity and the iron chelating capacity of the iron...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.